tiprankstipranks
Amplia Therapeutics Ltd. (INNMF)
OTHER OTC:INNMF

Amplia Therapeutics Ltd. (INNMF) Stock Price & Analysis

7 Followers

INNMF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.03 - $0.10
Previous Close$0.05
Volume180.67K
Average Volume (3M)16.80K
Market Cap
$9.75M
Enterprise Value$1.60M
Total Cash (Recent Filing)AU$14.61M
Total Debt (Recent Filing)AU$2.10M
Price to Earnings (P/E)-3.3
Beta0.19
May 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding194,006,395
10 Day Avg. Volume23,301
30 Day Avg. Volume16,800
Standard Deviation0.32
R-Squared0.00798
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

26.13%0.00%0.03%73.84%
26.13%
Insiders
0.03% Other Institutional Investors
73.84% Public Companies and
Individual Investors

INNMF FAQ

What was Amplia Therapeutics Ltd.’s price range in the past 12 months?
Amplia Therapeutics Ltd. lowest stock price was $0.03 and its highest was $0.10 in the past 12 months.
    What is Amplia Therapeutics Ltd.’s market cap?
    Currently, no data Available
    When is Amplia Therapeutics Ltd.’s upcoming earnings report date?
    Amplia Therapeutics Ltd.’s upcoming earnings report date is May 27, 2024 which is in 60 days.
      How were Amplia Therapeutics Ltd.’s earnings last quarter?
      Amplia Therapeutics Ltd. released its earnings results on Nov 20, 2023. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
        Is Amplia Therapeutics Ltd. overvalued?
        According to Wall Street analysts Amplia Therapeutics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Amplia Therapeutics Ltd. pay dividends?
          Amplia Therapeutics Ltd. does not currently pay dividends.
          What is Amplia Therapeutics Ltd.’s EPS estimate?
          Amplia Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Amplia Therapeutics Ltd. have?
          Amplia Therapeutics Ltd. has 194,006,400 shares outstanding.
            What happened to Amplia Therapeutics Ltd.’s price movement after its last earnings report?
            Amplia Therapeutics Ltd. reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 200%.
              Which hedge fund is a major shareholder of Amplia Therapeutics Ltd.?
              Currently, no hedge funds are holding shares in INNMF
              ---

              Amplia Therapeutics Ltd. Stock Smart Score

              6
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              -23.07%
              12-Months-Change

              Fundamentals

              Return on Equity
              -27.36%
              Trailing 12-Months
              Asset Growth
              -19.28%
              Trailing 12-Months

              Company Description

              Amplia Therapeutics Ltd.

              Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Bristol-Myers Squibb
              Axsome Therapeutics
              Merck & Company
              GlaxoSmithKline
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis